Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,853 papers from all fields of science
Search
Sign In
Create Free Account
Apligraf
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
Apligraf application (procedure)
Broader (1)
Collagen
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Epidermal stem cells are preserved during commercial-scale manufacture of a bilayered, living cellular construct (Apligraf®).
Mark W. Carlson
,
Katie Faria
,
Y. Shamis
,
Jonathan Leman
,
V. Ronfard
,
J. Garlick
Tissue Engineering. Part A
2011
Corpus ID: 206259969
It is unknown if epidermal stem cells are maintained during the commercial-scale manufacture of Apligraf, a bilayered living…
Expand
2010
2010
Initial clinical experience using a novel ultraportable negative pressure wound therapy device.
Kenton D. Fong
,
Dean Hu
,
+4 authors
A. Chang
Wounds (King of Prussia, Pa.)
2010
Corpus ID: 9712575
UNLABELLED Background. Traditional negative pressure wound therapy (NPWT) devices, such as the electrically powered V.A.C…
Expand
Review
2002
Review
2002
Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
M. Curran
,
G. Plosker
BioDrugs
2002
Corpus ID: 24974756
UNLABELLED The bilayered bioengineered skin substitute (BBSS) [Apligraf] is used for the treatment of venous leg ulcers and…
Expand
2002
2002
The role of graftskin (Apligraf) in difficult-to-heal venous leg ulcers.
Y. M. Bello
,
A. Falabella
Journal of Wound Care
2002
Corpus ID: 8955797
A relatively recent option for treating leg ulcers that have lasted longer than a month is to use living bilayered skin…
Expand
2002
2002
Modulating Diseased Skin with Tissue Engineering: Actinic Purpura Treated with Apligraf
M. N. Banta
,
R. Kirsner
Dermatologic Surgery
2002
Corpus ID: 1819342
BACKGROUND Actinic purpura (AP) is an important medical issue and quality of life issue in the elderly. Current treatment of AP…
Expand
2001
2001
Cost-effectiveness of Apligraf in the treatment of venous leg ulcers.
Sibbald Rg
,
G. Torrance
,
Walker
,
C. Attard
,
P. MacNeil
Ostomy/Wound Management
2001
Corpus ID: 19980963
Venous ulcers are the most common chronic wounds of the lower leg. Skin substitutes recently have been introduced to stimulate…
Expand
2000
2000
Use of human skin equivalent Apligraf for in vitro assessment of cumulative skin irritation potential of topical products.
J. Medina
,
de Brugerolle de Fraissinette
,
+5 authors
A. Cordier
Toxicology and Applied Pharmacology
2000
Corpus ID: 24674895
The main goal of the present study was to investigate the response of the human skin equivalent Apligraf in vitro to the…
Expand
2000
2000
Health-related quality of life in venous leg ulcer patients successfully treated with Apligraf: a pilot study.
S. Mathias
,
L. Prebil
,
W. Boyko
,
J. Fastenau
Advances in Skin & Wound Care
2000
Corpus ID: 23102358
Apligraf (Graftskin) is a bilayered, living human skin construct that is indicated for use with standard therapeutic compression…
Expand
Highly Cited
1998
Highly Cited
1998
Tissue engineered skin : Apligraf, a bi-layered living skin equivalent
Trent Jf
,
Kirsner Rs
1998
Corpus ID: 221612408
Driven by the need for a readily available, non-immunological tissue that possesses many of the characteristics of normal human…
Expand
Review
1998
Review
1998
Tissue engineering and the development of Apligraf a human skin equivalent.
W. Eaglstein
,
V. Falanga
Advances in wound care : the journal for…
1998
Corpus ID: 7449403
In recent years, skin grafting has evolved from the initial autograft and allograft preparations to biosynthetic and tissue…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required